Literature DB >> 6489539

Consequences of intrauterine contraception in diabetic women.

S O Skouby, L Mølsted-Pedersen, A Kosonen.   

Abstract

A study has been performed covering the clinical consequences of copper intrauterine device insertion in 103 insulin-dependent women and in 119 nondiabetic control subjects. Furthermore, the progress of corrosion has been measured in 15 intrauterine devices removed from diabetic women, and the results were compared with data obtained from nondiabetic women. The clinical data did not reveal any differences in the total continuation rates or in the removal rates because of accidental pregnancy or pelvic inflammation between the diabetic and the nondiabetic women after 3 and 12 months. Also, the maximal depth of corrosion as well as the distribution and the biochemical constitution of the corrosion products deposited on the copper wires were found identical in the two groups studied.

Entities:  

Keywords:  Anatomy; Biology; Comparative Studies; Contraception; Contraception Termination; Contraceptive Methods; Diabetes Mellitus; Diseases; Endocrine Effects; Endocrine System; Evaluation; Examinations And Diagnoses; Family Planning; Histology; Iud; Iud, Copper Releasing; Laboratory Examinations And Diagnoses; Physiology; Research Methodology; Studies

Mesh:

Year:  1984        PMID: 6489539

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review.

Authors:  Norman D Goldstuck; Petrus S Steyn
Journal:  ISRN Obstet Gynecol       Date:  2013-12-11

2.  Contraceptive Options Following Gestational Diabetes: Current Perspectives.

Authors:  Ashley M Turner; Emily A Donelan; Jessica W Kiley
Journal:  Open Access J Contracept       Date:  2019-10-22

3.  Diabetes and pregnancy: an endocrine society clinical practice guideline.

Authors:  Ian Blumer; Eran Hadar; David R Hadden; Lois Jovanovič; Jorge H Mestman; M Hassan Murad; Yariv Yogev
Journal:  J Clin Endocrinol Metab       Date:  2013-11       Impact factor: 5.958

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.